Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Johnson & Johnson announces completion of Novira Therapeutics, Inc. acquisition
Saturday, December 05, 2015Johnson Johnson announced the completion of the acquisition of Novira Therapeutics Inc a privately held clinicalstage biopharmaceutical company developing innovative therapies for curative treatment of chronic hepatitis B virus HBV infection The tra...
AstraZeneca Pharma India to close Bengaluru API unit
Friday, December 04, 2015Drug firm AstraZeneca Pharma India will close its Active Pharmaceutical Ingredient API unit at Bengaluru due to low demand for the product in the export markets The Board of Directors of the company at its meeting held on December has decided to c...
Shkreli's KaloBios buys Chagas disease drug rights, shares soar
Friday, December 04, 2015KaloBios Pharmaceuticals Inc which recently appointed controversial head of Turing Pharmaceuticals Martin Shkreli as CEO said it was acquiring worldwide rights to a compound being developed for the treatment of Chagas disease The companys shares ros...
Innovus Pharma signs exclusive license and distribution agreement with Bio Task for Malaysia
Friday, December 04, 2015Innovus Pharmaceuticals Inc announced it has entered into an exclusive license and distribution agreement with Bio Task SND BHD a Malaysia company Bio Task Pursuant to the agreement Innovus Pharma granted to Bio Task an exclusive license to market an...
Novo Nordisk got $130M offer for NC drug plant
Friday, December 04, 2015The megadeal that lured a Danish drug company to the state could exceed million according to documents obtained by The Associated Press highlighting the underreported scale of sweeteners local governments offer to employers The deal that steered ab...
Alexion's $550,000 bone drug too expensive for Britain
Thursday, December 03, 2015A new drug to treat a rare inherited bone disorder from Alexion Pharmaceuticals ALXNO that costs more than a year for each patient has been deemed too expensive by Britains health cost watchdog NICE The case highlights the skyhigh price of some med...
Goldman Sachs invests US$20 Million in Ascletis
Thursday, December 03, 2015Ascletis a Chinabased biotechnology company focused on innovative drug development announced today that Goldman Sachs completed a US million investment in the company So far Ascletis has completed two rounds of financing within the past two months Th...
Biovista Inc. announces Drug Repositioning Collaboration with Astellas Pharma
Thursday, December 03, 2015Biovista announced today that it has entered into a drug repositioning collaboration with Astellas Pharma Inc The collaboration is focused on identifying new indications for a number of undisclosed Astellas compounds using Biovistas Clinical Outcome...
Charterhouse weighs $637 million sale of Italian drug firm Doc Generici
Thursday, December 03, 2015European buyout firm Charterhouse CHCAPUL has hired Londonbased LEK Consulting to provide strategic advice to the Italian generic drugs company Doc Generici which could lead to a sale next year sources familiar with the matter said Charterhouse want...
Daiichi Sankyo to close its research subsidiary, U3 Pharma GmbH
Wednesday, December 02, 2015Daiichi Sankyo Company Limited announced its decision to close its research subsidiary U Pharma GmbH Munich Germany U Daiichi Sankyo intends to strengthen its global research and development capabilities by increasing efficiency and streamlining pro...
